SD

Sri Devi Bukka

Director Director DIN 08692162
DIN 08692162 First appointment Feb 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2020
Shareholding value Locked Premium profile

About Sri Devi Bukka

Data last updated:

Sri Devi Bukka has 6 years in corporate governance. Formerly with 1 company, such as Hariox Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08692162
Primary Designation Director
First Appointment 06 Feb 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Hariox Therapeutics Private Limited U24230TG2020PTC139035
Director06 Feb 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hariox Therapeutics Private Limited
Premium access

Shareholding and investment profile for Sri Devi Bukka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sri Devi Bukka

Sri Devi Bukka has 6 years in corporate governance. Formerly with 1 company, such as Hariox Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

Sri Devi Bukka is associated with 0 companies as a director.

Sri Devi Bukka has expertise in General Business.

Sri Devi Bukka has 6 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available